IRIS
AMOROSO, Luigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.383
EU - Europa 1.326
AS - Asia 778
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
AF - Africa 1
Totale 3.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.360
CN - Cina 356
UA - Ucraina 258
TR - Turchia 239
IE - Irlanda 225
SE - Svezia 206
IT - Italia 161
GB - Regno Unito 156
IN - India 136
FR - Francia 111
DE - Germania 109
FI - Finlandia 44
RU - Federazione Russa 34
SG - Singapore 33
CA - Canada 23
BE - Belgio 8
CZ - Repubblica Ceca 7
VN - Vietnam 7
IR - Iran 4
PL - Polonia 3
BR - Brasile 2
EU - Europa 2
MK - Macedonia 2
BD - Bangladesh 1
IL - Israele 1
JP - Giappone 1
MU - Mauritius 1
NL - Olanda 1
RO - Romania 1
Totale 3.492
Salva come PNG Salva come JPEG
Città #
Jacksonville 277
Chandler 256
Dublin 224
Southend 126
Dearborn 120
Izmir 108
Princeton 101
Nanjing 85
Ann Arbor 62
Beijing 58
Ashburn 52
New York 48
Wilmington 47
Cambridge 46
Nanchang 40
Chieti 34
Woodbridge 29
Boardman 26
Houston 26
Altamura 22
Ottawa 20
Shenyang 20
Hebei 19
Singapore 17
Jiaxing 16
Hefei 15
Kunming 15
Changsha 14
Tianjin 14
Augusta 9
Düsseldorf 9
Hangzhou 9
Jinan 9
Ningbo 8
Washington 8
Brussels 7
Dong Ket 7
Grevenbroich 7
Guangzhou 7
Leawood 7
Falls Church 6
San Mateo 6
Auburn Hills 5
Brno 5
Lanzhou 5
Los Angeles 5
Norwalk 5
Rome 5
Ardabil 4
Ferrara 4
Milan 4
Orange 4
Civitanova Marche 3
Fuzhou 3
Nürnberg 3
Xian 3
Zhengzhou 3
Bangalore 2
Bari 2
Brescia 2
Hanover 2
Jesi 2
Kocaeli 2
Kraków 2
Maser 2
Munich 2
Paris 2
Seattle 2
Skopje 2
Taizhou 2
Termoli 2
Toronto 2
Walnut 2
Brasschaat 1
Campobasso 1
Canosa Di Puglia 1
Cedar Knolls 1
Changchun 1
Chengdu 1
Chongqing 1
Como 1
Dalmine 1
Grafing 1
Guido 1
Haikou 1
L'aquila 1
Lucera 1
Martinsicuro 1
Melzo 1
Montreal 1
Moscow 1
Nanticoke 1
Napoli 1
Olomouc 1
Omegna 1
Perugia 1
Pescara 1
Pisa 1
Port Louis 1
Pune 1
Totale 2.156
Salva come PNG Salva come JPEG
Nome #
Therapy of glucocorticoid induced osteoporosis 169
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 113
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 111
Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane 109
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici] 105
Proteomic analysis of protein adsorption capacity of different haemodialysis membranes 102
Proteomics characterization of protein adsorption onto hemodialysis membranes 98
Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis 97
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 96
Emodiafiltrazione (HDF) con polisulfone (PSF) e neuropatia periferica: una valida alternativa al trattamento emodialitico tradizionale RDT) 95
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations 94
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 94
Modificazioni emodinamiche sistemiche e renali indottie dalla somministrazione a breve ed a lungo termine della lacidipina 91
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 91
On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria.] 89
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 89
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 88
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis 84
Emodiafiltrazione (HDF) con membrane in polisulfone (PSF) ed eritropoietina ricombinante umana (r-HuEPO): si puo' fare di meglio? 83
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 81
Emodiafiltrazione con polisulfone: effetti elettrofisiologici sulla neuropatia uremica 81
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 81
La risposta simpatica cutanea nei pazienti emodializzati 78
Vascular inflammation in end-stage renal disease: the red blood cell connection 77
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint 74
Blood volume controlled hemodialysis in hypotension-prone patients: a randomized, multicenter controlled trial 72
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes 72
Sjogren’s syndrome associated with haemolytic-uraemic syndrome as presenting clinical manifestation: a case report 71
Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients 67
Management of IgA nephropathy 67
Comparison of mammographic and industrial films in dialysis patients 67
Variazioni elettrofisiologiche cerebrali indotte dal trattamento con eritropoietina ricombinante umana (r-HuEPO) in pazienti in trattamento emodialitico convenzionale (RDT) 65
Hemodynamic-guided therapy in essential hypertension: a new pathophysiological approach 65
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 65
Nefropatie tubulo-interstiziali 62
Approccio diagnostico al sanguinamento gastrointestinale occulto nel paizente in trattamento emodialitico 61
Do haemodialysis membranes influence atherosclerosis? A one-year prospective study 61
Pathophysiological features of hypertension in CAPD: hemodynamic pattern evaluated by impedance cardiography 60
Cutting Balloon Angioplasty (CBA) for the Treatment of Renal Artery Fibromuscular Dysplasia (FMD) in Six Patients: 5-Year Long-Term Results 59
Pro-atherogenic effect of uraemic red blood cell (RBC): role of RBC surface-exposed phosphatidylserine 58
L-carnitine may decrease platelet activation response with phosphatidylserine exposure in chronic uraemia 58
Increased adhesion of uraemic red blood cells to vascular endothelium causes reduction of endothelial nitric oxide synthase expression 57
Pro-inflammatory effects of erythrocytes from uremic patients on cultured human endothelial cells: insights into the signaling pathways 56
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E.DOSE). 55
null 55
Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia 47
Insufficienza renale acuta 46
Toward personalized haemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fungerprint 9
Totale 3.725
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.194
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020844 218 48 7 34 68 70 127 77 36 91 62 6
2020/2021346 57 4 49 4 34 70 7 5 16 53 29 18
2021/2022246 9 3 6 74 16 3 6 13 23 9 27 57
2022/2023680 59 85 40 88 64 140 38 40 96 5 11 14
2023/2024369 22 9 20 5 10 174 75 8 0 2 5 39
2024/202545 45 0 0 0 0 0 0 0 0 0 0 0
Totale 3.725